Invesco Biotechnology & Genome ETF (PBE) holdings
Top holdings
The 10 largest positions make up 46.5% of the fund, as reported on Aug 28, 2026.
Frequently asked questions
What are the top holdings of PBE?
As of Aug 28, 2026, the largest positions in Invesco Biotechnology & Genome ETF are CDNA (5.5%), AMGN (5.4%), REGN (5.3%), VRTX (5.2%), RPRX (4.8%).
How concentrated is PBE?
The 10 largest positions make up 46.5% of Invesco Biotechnology & Genome ETF, as reported on Aug 28, 2026.
Fund holdings are reported periodically and are a snapshot of a past date, not a live position list — what the fund holds today may differ. Weights cover only the largest positions shown, not the whole portfolio.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
